Skip to main content
. 2018 Oct 29;36(45):6606–6614. doi: 10.1016/j.vaccine.2018.09.026

Fig. 4.

Fig. 4

Key messages and lessons learned. Key messages and lessons learned through the development of affordable OCVs through a variety of partnerships inclusive of private sector, funders, NGOs and public sector.